C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/82 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01) A61K 38/13 (2006.01) A61K 38/20 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61P 3/10 (2006.01) C12N 15/24 (2006.01) C12N 15/60 (2006.01)
Patent
CA 2596332
The invention is directed to a new method for the treatment of new onset Type I diabetes in mammals or for the treatment of pre-Type I diabetic mammals where the method comprises administering (a) anti-T cell therapy to the mammal and administering (b) an autoantigen and optional mucosal antigen composition, wherein (a) and (b) are administered concurrently or sequentially Exemplified is a treatment using a mixture of anti-CD3 antibodies, a glutamic acid decarboxylase (GAD) autoantigen, and an immunoregulatory cytokine Canme GAD sequences are also disclosed.
L'invention concerne un nouveau procédé pour le traitement d'un diabète de type I nouvellement apparu chez des mammifères ou pour le traitement de mammifères atteints de prédiabète de type I, lequel procédé comprend l'administration au mammifère (a) d'un traitement contre les lymphocytes T et l'administration (b) d'un antigène et en option d'une composition antigénique mucosale, (a) et (b) étant administrés en même temps ou l'un après l'autre. Un traitement utilisant un mélange d'anticorps anti-CD3 est donné en exemple, et un autoantigène de l'acide glutamique décarboxylase (GAD) et une séquence GAD canine de cytokine immunorégulatrice sont également présentées.
Ainley William Michael
Armstrong Janna M.
Jevnikar Anthony
Ma Shengwu
Merlo Donald Joseph
Dow Agrosciences Llc
Jevnikar Anthony
Ma Shengwu
Plantigen Inc.
Sim & Mcburney
LandOfFree
Anti-t cell and autoantigen treatment of autoimmune disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-t cell and autoantigen treatment of autoimmune disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-t cell and autoantigen treatment of autoimmune disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1943637